1Johnson KA, Jones K, Holman BL. Preclinical Prediction of Alzheimer's disease using SPE CT[J]. Neurology, 1998, 50(6):1563-1571.
2McKelvey R, Bergman H, Stern J. Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with mild memory loss[J]. Can J Neurol Sci, 1999,26(1) :23-28.
3Krasuski JS, Alexander GE, Horwitz B, et al. Volumes of medial temporal lobe structures in patients with Alzheimer'sdisease and mild cognitive impairment(and in healthy controls)[J]. Biol Psychiatry,1998,43(1):60-68.
5Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease? [J]. Lancet Neurol, 2004,3(4) :246-248.
6McGeer PL, Schulzer M, McGeer GE. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease., a review of 17 epidemiologic studies[J].Neurology, 1996,47(2) :425-432.
7McGeer EG, McGeer PL. Inflammatory Process in Alzheimer's disease[J]. Prog Neuro-Psychopharmacol Biol Psychiatry,2003,27(5) :741-749.
9Mesulam M, Shaw P, Mash D, et al. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-ADcontinuum[J]. Ann Neurol, 2004,55(6) :815-828.
7Griffin WS, Sheng JG, Royston MC, et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle"in disease progression. Brain Pathol, 1998, 8: 65-72.
8McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer's disease. Exp Gerontol, 1998, 33: 371-378.
9American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. Washington: American Psychiatric Association, 1994.92-94.
